Bliss GVS Pharma Limited has informed the Exchange about a Copy of the Newspaper Publication regarding the Submission of the Newspaper Publication regarding the 40th Annual General Meeting of the Company.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has published a newspaper notice informing shareholders about its 40th AGM scheduled for Thursday, July 31, 2025, at 11:30 a.m. (IST), to be held via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The notice highlights that electronic copies of the AGM notice and Annual Report for FY 2024-25 will be emailed to shareholders. The Board, at its meeting on May 12, 2025, had recommended a Final Dividend of 50% (Re. 0.50 per equity share on a face value of Re. 1 each) for FY ended March 31, 2025, subject to shareholder approval at the AGM. The Record Date for eligibility is Thursday, July 24, 2025. Shareholders have been advised to update bank and email details with the RTA (MUFG Intime) or Depository Participants to receive dividends electronically and avoid TDS-related issues.
Shareholders holding shares as of the July 24, 2025 Record Date stand to receive a Re. 0.50 per share Final Dividend if approved at the AGM. The publication is a routine compliance filing and does not indicate any change in business fundamentals, though it confirms the company's continued dividend-paying track record.